This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Solid Organ Transplantation
  • /
  • An Efficacy and Safety Study of Imlifidase in Trea...
Clinical trial

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Read time: 1 mins
Last updated:8th Jun 2020
Identifier: NCT03897205
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest